Semaglutide, a GLP-1 receptor agonist, preserves brain microcirculation and neurovascular unit integrity in a metabolic syndrome experimental model
2023; Elsevier BV; Volume: 455; Linguagem: Catalão
10.1016/j.jns.2023.121686
ISSN1878-5883
AutoresVanessa Estato, Nathalie Obadia, Paulo Henrique Chateaubriand, Vivian Figueiredo, Marcela Curty, Mariana Fernandes Costa, Renata Lustosa, Lucas Antônio Miranda Ferreira, Joana C. d’Avila, Hugo Faria,
Tópico(s)Diabetes Treatment and Management
Referência(s)